Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001641172-25-006278
Filing Date
2025-04-25
Accepted
2025-04-25 17:13:47
Documents
4

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 602141
2 logo_01.jpg GRAPHIC 4839
3 chart_001.jpg GRAPHIC 202522
4 logo_001.jpg GRAPHIC 9176
  Complete submission text file 0001641172-25-006278.txt   901682
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-286662 | Film No.: 25875195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)